300705 Hunan Jiudian Pharmaceutical
- 24.03
- +0.27+1.14%
Hunan Jiudian Pharmaceutical News
Hunan Jiudian Pharmaceutical: Announcement on the Pre-disclosure of Shareholding Reduction by Shareholders.
Hunan Jiudian Pharmaceutical: Announcement on the Adjustment of the Conversion Price of Juidian 02 Convertible Bonds
Hunan Jiudian Pharmaceutical: Announcement on the Attribution Results of the Second Vesting Period of the Restricted Stock Incentive Plan for 2022 and the Listing of the Stocks
Hunan Jiudian Pharmaceutical: Legal opinion on matters relating to the adjustment of the company's 2022 restricted stock incentive plan, the abolition of some restricted shares, and the achievement of ownership conditions during the second vesting period
Hunan Jiudian Pharmaceutical: Announcement on matters relating to the adjustment of the 2022 Restricted Stock Incentive Plan
Hunan Jiudian Pharmaceutical: Supervisory Board's Review Opinions on the List of Incentive Recipients for the Second Vesting Period of the 2022 Restricted Stock Incentive Plan
Hunan Jiudian Pharmaceutical: Announcement on the achievements of the vesting conditions for the second vesting period of the 2022 Restricted Stock Incentive Plan
Hunan Jiudian Pharmaceutical: Announcement on the adjustment of the Jiudian to 02 conversion price
Hunan Jiudian Pharmaceutical: 2023 Equity Distribution Implementation Notice
Jiudian Pharmaceutical: Announcement on the 2023 Profit Distribution and Capital Transfer Plan from the Capital Provident Fund
Jiudian Pharmaceutical: An indicative announcement on the commencement of stock conversion from Jiudian Transfer 02
Jiudian Pharmaceutical: Notice on the voluntary commitment of the controlling shareholders, actual controllers and their co-actors not to reduce their holdings of the company\'s shares within the next six months
Jiudian Pharmaceutical: Announcement on the results of the first vesting period and the second batch of vesting results and stock listing of the 2022 Restricted Stock Incentive Plan
Jiudian Pharmaceutical: Announcement on the vesting results of the first vesting period of the 2022 Restricted Stock Incentive Plan and the listing of shares
Jiudian Pharmaceutical: Legal opinion of Hunan Qiyuan Law Firm on the adjustment of matters relating to the company\'s 2022 restricted stock incentive plan, the achievement of some of the first vesting period conditions for the first time, and the annulmen
Jiudian Pharmaceutical: Announcement on the achievement of the vesting conditions for the first vesting period of the 2022 Restricted Stock Incentive Plan
Jiudian Pharmaceutical: Supervisory Board\'s Review Opinions on the List of Incentive Targets for the First Vesting Period of the 2022 Restricted Stock Incentive Plan
Jiudian Pharmaceutical: Announcement on matters relating to adjustments to the 2022 restricted stock incentive plan
Jiudian Pharmaceutical: 2022 Equity Distribution Implementation Notice
Jiudian Pharmaceutical: Announcement on 2022 Profit Distribution Plan
Analysis
Price Target
No Data
No Data